Exclusive special offer and discount title banner vector image

UNITED STATES BIOPSY DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

United States Biopsy Devices Market by Product (Needle-Based Biopsy Guns (Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices), Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Other Products) Market by Application (Oncology, Gastroenterology, Pulmonology, Dermatology, Other Applications) Market by End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers)

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The United States biopsy devices market is anticipated to progress with a CAGR of 7.79% over the forecast period of 2024-2032 and is set to reach a revenue of $xx million by 2032. 

The United States biopsy devices market is experiencing an upsurge propelled by increased healthcare expenditure. This upswing reflects a commitment to investing in advanced medical technologies, including biopsy devices. The rising financial support enhances accessibility to advanced biopsy solutions, boosting improved diagnostic capabilities and healthcare outcomes across the nation.

A substantive trend developing in the market is the shift toward preventive healthcare. This strategic move aligns with a broader national focus on early detection and disease prevention. Biopsy devices are important in this preventive approach, facilitating timely identification and intervention. The emphasis on preventive healthcare positions biopsy devices as essential tools in advancing public health initiatives and reducing the overall burden of diseases in the United States.

United States Biopsy Devices Market

To Know More About This Report, Request a Free Sample Copy

Expanding applications across medical specialties contribute significantly to the dynamism of the United States biopsy devices market. Biopsy procedures are no longer confined to specific medical fields but are diversifying across disciplines such as oncology, cardiology, and gastroenterology. This versatility underscores the adaptability and relevance of biopsy devices in addressing a wide range of medical conditions, thereby solidifying their importance in the evolving domain of US healthcare. Hence, these factors are set to fuel the market’s growth in the United States during the forecast period.

The United States biopsy devices market segmentation includes product, application, and end use. The end use segment comprises hospitals, ambulatory surgical centers, and diagnostic centers. As primary centers for comprehensive healthcare delivery, hospitals are central to the diagnosis and treatment of various medical conditions. Biopsy devices within hospital settings facilitate the collection of tissue samples crucial for accurate diagnoses, contributing to the formulation of personalized treatment plans. 

In addition to hospitals, diagnostic centers form a crucial segment within the end use category of the biopsy devices market. These specialized facilities are dedicated to diagnostic imaging and related procedures, making them key stakeholders in the utilization of biopsy devices. Diagnostic centers leverage biopsy devices for their proficiency in obtaining tissue samples, which are essential for accurate and timely diagnoses. The prominence of biopsy devices in diagnostic centers aligns with the broader healthcare emphasis on early detection and preventive care, contributing to the overall efficiency and effectiveness of diagnostic services throughout the United States.

The strategic inclusion of hospitals and diagnostic centers in the end use segmentation reflects the versatile applications of biopsy devices in different healthcare settings. From the comprehensive services provided by hospitals to the specialized focus of diagnostic centers, the end use segment underscores the importance of biopsy devices in advancing diagnostics and personalized medicine across the varied sphere of the United States healthcare system.

Some of the leading players in the United States biopsy devices market are Cardinal Health, Boston Scientific, DTR Medical, Becton Dickinson and Company, Danaher Corporation, Argon Medical Devices, etc. 

Becton Dickinson and Company (BD) is a renowned global medical technology company headquartered in Franklin Lakes, New Jersey, US. BD is a leading provider of innovative medical devices, reagents, and laboratory equipment. The company is dedicated to advancing healthcare by improving medical discovery, diagnostics, and the delivery of care. BD’s diverse portfolio includes products for medication management to the development of new drugs.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million) 
Segments Analyzed
Product, Application, and End Use
Countries AnalyzedUnited States
Companies AnalyzedCardinal Health, Hologic Inc, Danaher Corporation, Conmed Corporation, Cook Medical, DTR Medical, Inrad Inc, Boston Scientific, Becton Dickinson and Company, Argon Medical Devices

TABLE OF CONTENTS

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
    6. MAJOR MARKET FINDINGS
      1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
      2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
      3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CANCER
      2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
    2. KEY RESTRAINTS
      1. HIGH RISK OF INFECTION FOR PATIENTS
      2. HIGH COST OF BIOPSY PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN THE HEALTHCARE EXPENDITURE
      2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
      3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
    2. PESTLE ANALYSIS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTIONS
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY PRODUCT
    1. NEEDLE- BASED BIOPSY GUNS
      1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
      2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
      3. CORE NEEDLE BIOPSY (CNB) DEVICES
    2. BIOPSY GUIDANCE SYSTEMS
    3. BIOPSY NEEDLES
    4. BIOPSY FORCEPS
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. ONCOLOGY
    2. GASTROENTEROLOGY
    3. PULMONOLOGY
    4. DERMATOLOGY
    5. OTHER APPLICATIONS
  7. MARKET BY END USE
    1. HOSPITALS
    2. AMBULATORY SURGICAL CENTERS
    3. DIAGNOSTIC CENTERS
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. CARDINAL HEALTH
      2. HOLOGIC INC
      3. DANAHER CORPORATION
      4. CONMED CORPORATION
      5. COOK MEDICAL
      6. DTR MEDICAL
      7. INRAD INC
      8. BOSTON SCIENTIFIC
      9. BECTON DICKINSON AND COMPANY
      10. ARGON MEDICAL DEVICES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES

TABLE 2: UNITED STATES BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: UNITED STATES BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: UNITED STATES BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: UNITED STATES BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: UNITED STATES BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: UNITED STATES BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: UNITED STATES BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: UNITED STATES BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: LIST OF MERGERS & ACQUISITIONS

TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 13: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: VALUE CHAIN ANALYSIS

FIGURE 4: UNITED STATES BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 5: UNITED STATES BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)

FIGURE 6: UNITED STATES BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023

FIGURE 7: UNITED STATES BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 8: UNITED STATES BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 9: UNITED STATES BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 10: UNITED STATES BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)

FIGURE 11: UNITED STATES BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)

FIGURE 12: UNITED STATES BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)

FIGURE 13: UNITED STATES BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)

FIGURE 14: UNITED STATES BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 15: UNITED STATES BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 16: UNITED STATES BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)

FIGURE 17: UNITED STATES BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 18: UNITED STATES BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 19: UNITED STATES BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)

FIGURE 20: UNITED STATES BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USE, IN 2023

FIGURE 21: UNITED STATES BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 22: UNITED STATES BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 23: UNITED STATES BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization
Request Free Sample